bioAffinity Technologies Welcomes New Board Members
November 29, 2017 11:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, Nov. 29, 2017 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics and therapeutics company, today announced the appointments of Stephen Squinto, Ph.D., and...
bioAffinity Technologies Announces $4 Million Series A Funding
July 19, 2017 15:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, July 19, 2017 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held company advancing early-stage cancer diagnostics and precision therapeutics, announced today that it raised...
bioAffinity Technologies Adds Four Scientists to Research & Commercialization Team
June 28, 2017 14:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, June 28, 2017 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held company advancing early stage cancer diagnostics and precision cancer therapeutics, today announced four...
bioAffinity Technologies Announces Award of European Union Patent
May 03, 2017 14:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, Texas, May 03, 2017 (GLOBE NEWSWIRE) -- bioAffinity Technologies announced that the European Patent Office (EPO) has issued a patent that protects the Company’s proprietary CyPath®...